In addition, some studies have found that LCAT expression and activity are downregulated in some cases of obesity and metabolic syndrome, possibly due to chronic low-grade inflammation, insulin resistance, and other factors [39,40]. This evidence concerns the gene LCAT and metabolic syndrome.